Pillstats
Rx only · Tablet, Film Coated · Oral

Dapagliflozin

Brands: Farxiga · Dapagliflozin

16 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US37 NDCs
16 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers17 labelers
Packages76
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 31 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.87$9.75$14.62$19.49Dec 2025May 2026Jul 2026
$2.112
Latest avg · Jul 15, 2026
-88%
Since Dec 17, 2025
16
Active US suppliers
27%
Top-2 supplier share*

Who makes it16 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown12SUPPLYING
Ascend Laboratories, LLCunknown8SUPPLYING
Sandoz Incunknown8SUPPLYING
AstraZeneca Pharmaceuticals LPunknown7SUPPLYING
Novadoz Pharmaceuticals LLCunknown6SUPPLYING
A-S Medication Solutionsunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown6SUPPLYING
AvKAREunknown4SUPPLYING
Aurobindo Pharma Limitedunknown4SUPPLYING
Biocon Pharma Incunknown4SUPPLYING
Cipla USA Inc.unknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Prasco Laboratoriesunknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

+ 2 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.